russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLCrussjcardiol-2063Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEWПРОПАФЕНОН: КЛИНИЧЕСКАЯ ФАРМАКОЛОГИЯ И ЭФФЕКТИВНОСТЬ ПРИ СУПРАВЕНТРИКУЛЯРНЫХ ТАХИАРИТМИЯХ (Часть вторая)PROPAPHENON: CLINICAL PHARMACOLOGY AND EFFICACY IN SUPRAVENTRICULAR ARRHYTHMIAS (PART 2)ПреображенскийД. В.PreobrazhenskyD. V.МареничА. В.MarenichA. V.АндрейченкоТ. А.AndreychenkoT. A.КиктевВ. Г.KiktevV. G.СидоренкоБ. А.SidorenkoB. A.Медицинский центр Управления делами Президента Российской Федерации. Кардиологический научно- производственный комплекс МЗРФ, МоскваRussian Federation200128102001057884Copyright © Преображенский Д.В., Маренич А.В., Андрейченко Т.А., Киктев В.Г., Сидоренко Б.А., 20012001Преображенский Д.В., Маренич А.В., Андрейченко Т.А., Киктев В.Г., Сидоренко Б.А.Preobrazhensky D.V., Marenich A.V., Andreychenko T.A., Kiktev V.G., Sidorenko B.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/2063

Пропафенон: клиническая фармакология и эффективность при суправентрикулярных тахиаритмиях (часть вторая).

Propaphenon: clinical pharmacology and efficacy in supraventricular arrhythmias (Part 2).

ReferencesHarron D.W.G., Brogden R.N. Propafenone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in cardiac arrhythmias. – Drugs, 1987; 34: 617-647.Harron D.W.G., Brogden R.N. Propafenone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in cardiac arrhythmias. – Drugs, 1987; 34: 617-647.Bryson H.M., Palmer K.J., Langtry H.D. et al. Propafenone: a reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias. – Drugs, 1993; 45 (1): 85-130.Bryson H.M., Palmer K.J., Langtry H.D. et al. Propafenone: a reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias. – Drugs, 1993; 45 (1): 85-130.Kishore A.G.R., Camm A.J. Guidelines for the use of propafenone in treating supraventricular arrhythmias. – Drugs, 1995; 50 (2): 250-262.Kishore A.G.R., Camm A.J. Guidelines for the use of propafenone in treating supraventricular arrhythmias. – Drugs, 1995; 50 (2): 250-262.Khan I.A. Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation. — J. Am. Coll. Cardiol., 2001; 37 92): 542-547.Khan I.A. Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation. — J. Am. Coll. Cardiol., 2001; 37 92): 542-547.Bellandi F. et al. The efficacy of intravenous propafenone and amiodarone in conversion of recent onset atrial fibrillation: A 1 year follow-up with oral treatment. — G. Ital. Cardiol., 1993; 23: 261-271.Bellandi F. et al. The efficacy of intravenous propafenone and amiodarone in conversion of recent onset atrial fibrillation: A 1 year follow-up with oral treatment. — G. Ital. Cardiol., 1993; 23: 261-271.Negrini M. et al. Propafenone compared with amiodarone for conversion of paroxysmal atrial fibrillation to sinus rhythm. — J. Amer. Coll.. Cardiol., 1991; 17: 131A (abstract).Negrini M. et al. Propafenone compared with amiodarone for conversion of paroxysmal atrial fibrillation to sinus rhythm. — J. Amer. Coll.. Cardiol., 1991; 17: 131A (abstract).Bertini G. et al. Alandi F. et al. Propafenone versus amiodarone in field treatment of primary atrial tachyarrhythmias. — J. Emerg. Med., 1990; 8: 15-20..Bertini G. et al. Alandi F. et al. Propafenone versus amiodarone in field treatment of primary atrial tachyarrhythmias. — J. Emerg. Med., 1990; 8: 15-20..Kingma J.H. et al. Acute pharmacological cardioversion of atrial fibrillation and flutter: the role of flecainide, propafenone and verapamil. — Am. J. Cardiol., 1992; 70: 56A-61A.Kingma J.H. et al. Acute pharmacological cardioversion of atrial fibrillation and flutter: the role of flecainide, propafenone and verapamil. — Am. J. Cardiol., 1992; 70: 56A-61A.Capucci A. et al. A placebo controlled study comparing oral propafenone to quinidine plus digoxin in conversion of recent onset atrial fibrillation. – Europ. Heart J., 1991; 12 (suppl.): 338 (abstract).Capucci A. et al. A placebo controlled study comparing oral propafenone to quinidine plus digoxin in conversion of recent onset atrial fibrillation. – Europ. Heart J., 1991; 12 (suppl.): 338 (abstract).Capucci A. et al. Conversion of recent onset atrial fibrillation by single loading dose of propafenone or flecainide. — Am. J. Cardiol., 1994; 74: 503-505.Capucci A. et al. Conversion of recent onset atrial fibrillation by single loading dose of propafenone or flecainide. — Am. J. Cardiol., 1994; 74: 503-505.Bianconi L. et al. Effectveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset. – Am. J. Cardiol., 1989; 64: 335-338.Bianconi L. et al. Effectveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset. – Am. J. Cardiol., 1989; 64: 335-338.Margheri M. et al. Efficacy of intravenous and per oral propafenone in the ambulatory treatment of recent onset atrial fibrillationus rhythm. — G. Ital. Cardiol., 1992; 22: 257-265.Margheri M. et al. Efficacy of intravenous and per oral propafenone in the ambulatory treatment of recent onset atrial fibrillationus rhythm. — G. Ital. Cardiol., 1992; 22: 257-265.Vita J.A. et al. The efficacy of intravenous propafenone for the acute management of atrial fibrillation. – Am. J. Cardiol., 1989; 63: 1275-1278.Vita J.A. et al. The efficacy of intravenous propafenone for the acute management of atrial fibrillation. – Am. J. Cardiol., 1989; 63: 1275-1278..Kochiadakis G.E. et al. Amiodarone versus propafenone for cardioversion of chronic atrial fibrillation: results of a randomized, controlled study. — J. Am. Coll. Cardiol., 1999; 33: 966-971..Kochiadakis G.E. et al. Amiodarone versus propafenone for cardioversion of chronic atrial fibrillation: results of a randomized, controlled study. — J. Am. Coll. Cardiol., 1999; 33: 966-971.Capucci A. et al. Minimal effective concentration value of propafenone and 5-hydroxypropafenone in acute and chronic therapy. – Cardiovascular. Drugs Therapy, 1990; 4: 281-287.Capucci A. et al. Minimal effective concentration value of propafenone and 5-hydroxypropafenone in acute and chronic therapy. – Cardiovascular. Drugs Therapy, 1990; 4: 281-287.Boriani G. et al. Propafenone for conversion of recent—onset atrial fibrillation: A controlled comparison between oral loading dose and intravenous administation. – Chest, 1995; 108: 355-358.Boriani G. et al. Propafenone for conversion of recent—onset atrial fibrillation: A controlled comparison between oral loading dose and intravenous administation. – Chest, 1995; 108: 355-358.Botto G.L. et al. A randomized, crossover, controlled comparison of oral loading dose versus intravenous infusion of propafenone in recent onset atrial fibrillation. – Pacing Clin Electrophysiol., 1998; 21: 240-244.Botto G.L. et al. A randomized, crossover, controlled comparison of oral loading dose versus intravenous infusion of propafenone in recent onset atrial fibrillation. – Pacing Clin Electrophysiol., 1998; 21: 240-244.Reinold S.C. et al. Propafenone versus sotalol for suppression of rcurrent symptomatic atrial fibrillation. – Am. J. Cardiol., 1993; 71: 558-563.Reinold S.C. et al. Propafenone versus sotalol for suppression of rcurrent symptomatic atrial fibrillation. – Am. J. Cardiol., 1993; 71: 558-563.Boriani G. et al. Conversion of recent onset atrial fibrillation to sinus rhythm: effect of different drug protocols. — Pacing Clin Electrophysiol., 1998; 21: 2470-2474.Boriani G. et al. Conversion of recent onset atrial fibrillation to sinus rhythm: effect of different drug protocols. — Pacing Clin Electrophysiol., 1998; 21: 2470-2474.Boriani G. et al. Oral propafenone to convert recent onset atrial fibrillation in patients with and without underlying heart disease: A randomized, controlled trial. – Ann. Intern. Med., 1997; 126: 621-625.Boriani G. et al. Oral propafenone to convert recent onset atrial fibrillation in patients with and without underlying heart disease: A randomized, controlled trial. – Ann. Intern. Med., 1997; 126: 621-625.Azpitarte J. et al. Value of single oral loading dose of propafenone in converting recent onset atrial fibrillation: Results of a randomized, double-blind, controlled study. Europ. Heart J., -1997; 18: 1649-1654.Azpitarte J. et al. Value of single oral loading dose of propafenone in converting recent onset atrial fibrillation: Results of a randomized, double-blind, controlled study. Europ. Heart J., -1997; 18: 1649-1654.Botto G.L et al. Conversion of recent onset atrial fibrillation to sinus rhythm using a single loading oral dose of propafenone: Comparison of two regims. – Int. J. Cardiol., 1997; 58: 55-61.Botto G.L et al. Conversion of recent onset atrial fibrillation to sinus rhythm using a single loading oral dose of propafenone: Comparison of two regims. – Int. J. Cardiol., 1997; 58: 55-61.Boriani G. et al. Oral loading with propafenone: A placebo-controlled study in elderly and nonelderly patients with recent onset atrial fibrillation. – Pacing Clin Electrophysiol., 1998; 21: 2465-2469.Boriani G. et al. Oral loading with propafenone: A placebo-controlled study in elderly and nonelderly patients with recent onset atrial fibrillation. – Pacing Clin Electrophysiol., 1998; 21: 2465-2469.Botto G.L. et al. Сonversion of recent onset atrial fibrillation with single loading dose of propafenone: Is in-hospital admission absolutely necessary? – Pacing Clin Electrophysiol., 1996; 19: 1939-1943.Botto G.L. et al. Сonversion of recent onset atrial fibrillation with single loading dose of propafenone: Is in-hospital admission absolutely necessary? – Pacing Clin Electrophysiol., 1996; 19: 1939-1943.Capucci A. et al. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent-onset atrial fibrillation to sinus rhythm. — Int. J. Cardiol., 1994; 41: 305-313.Capucci A. et al. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent-onset atrial fibrillation to sinus rhythm. — Int. J. Cardiol., 1994; 41: 305-313.Blanc J.J. et al. Comparison of oral loading dose of propafenone and amiodarone for conversion of recent-onset atrial fibrillation: A prospective parallel placebo-controlled multicentre study. – Am. J. Cardiol., 1999; 84: 1029-1032.Blanc J.J. et al. Comparison of oral loading dose of propafenone and amiodarone for conversion of recent-onset atrial fibrillation: A prospective parallel placebo-controlled multicentre study. – Am. J. Cardiol., 1999; 84: 1029-1032.Capucci A. et al. Conversion of recent onset atrial fibrillation by single loading dose of propafenone or flecainide. — Am. J. Cardiol., 1994; 74: 503-505.Capucci A. et al. Conversion of recent onset atrial fibrillation by single loading dose of propafenone or flecainide. — Am. J. Cardiol., 1994; 74: 503-505.Capucci A. et al. Safety of oral propafenone in the conversion recent￾onset atrial fibrillation to sinus rhythm: A prospective parallel placebo-controlled multicenter study. – Am. J. Cardiol., 1999; 84: 1029-1032.Capucci A. et al. Safety of oral propafenone in the conversion recent￾onset atrial fibrillation to sinus rhythm: A prospective parallel placebo-controlled multicenter study. – Am. J. Cardiol., 1999; 84: 1029-1032.Bianconi L. et al. Effects of oral propafenone administration defore electrical cardioversion of chronic atrial fibrillation: A placebo￾controlled study. — J. Am. Coll.. Cardiol., 1996; 28 (3): 700-706.Bianconi L. et al. Effects of oral propafenone administration defore electrical cardioversion of chronic atrial fibrillation: A placebo￾controlled study. — J. Am. Coll.. Cardiol., 1996; 28 (3): 700-706.Antmann E,M. et al. Long-term oral propafenone threapy for suppression of refractory symptomatic atrial fibrillation and flutter. – J. Am. Coll. Cardiol., 1988; 12: 1005-1111.Antmann E,M. et al. Long-term oral propafenone threapy for suppression of refractory symptomatic atrial fibrillation and flutter. – J. Am. Coll. Cardiol., 1988; 12: 1005-1111.Cobbe S.M. A randomised, placebo controlled trial of propafenone in the prophylaxis of of paroxysmal paroxysmal tachyarrhthmias. – J. Am. Coll. Cardiol., 1994; 23 (suppl. A): 251A (abstract). 32. Cobbe S.M. Drug therapy of supraventricular tachyarrhythmias – based on efficacy or futility? – Europ. Heart J., 1994; 15 (suppl. A): 22-26.Cobbe S.M. A randomised, placebo controlled trial of propafenone in the prophylaxis of of paroxysmal paroxysmal tachyarrhthmias. – J. Am. Coll. Cardiol., 1994; 23 (suppl. A): 251A (abstract). 32. Cobbe S.M. Drug therapy of supraventricular tachyarrhythmias – based on efficacy or futility? – Europ. Heart J., 1994; 15 (suppl. A): 22-26.Reinold S.C. et al. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. – Am. J. Cardiol., 1993; 71: 558-563.Reinold S.C. et al. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. – Am. J. Cardiol., 1993; 71: 558-563.Richardi E. et al. Propafenone versus hydroquinidine in long-term pharmacologic prophilaxis of atrial fibrillation. – Cardiology, 1992; 37: 123-127.Richardi E. et al. Propafenone versus hydroquinidine in long-term pharmacologic prophilaxis of atrial fibrillation. – Cardiology, 1992; 37: 123-127.Chimenti M. et al. Flecainide versus propafenone in the prevention of paroxysmal atrial fibrillation: A long-term randomised muli-centre study. J. Am. Coll. Cardiol., 1994; 16 (suppl.): 91A (abstract)..Chimenti M. et al. Flecainide versus propafenone in the prevention of paroxysmal atrial fibrillation: A long-term randomised muli-centre study. J. Am. Coll. Cardiol., 1994; 16 (suppl.): 91A (abstract)..Reinold S.C. et al. Propafenone for treatment of supraventricular tachycardia: and atrial fibrillation.: A meta-analysis. – Am. J. Cardiol., 1998; 82: 66N-71N..Reinold S.C. et al. Propafenone for treatment of supraventricular tachycardia: and atrial fibrillation.: A meta-analysis. – Am. J. Cardiol., 1998; 82: 66N-71N..Mannino M.M. et al. Current teatment options for paroxysmal supraventricular tachycardia. – Am. Heart J., 1994; 127: 475-480.Mannino M.M. et al. Current teatment options for paroxysmal supraventricular tachycardia. – Am. Heart J., 1994; 127: 475-480.Santinelli V. et al. Paroxysmal supraventricular tachycardia: Experience with propafenone. – Angiology, 1989; 40: 563-568.Santinelli V. et al. Paroxysmal supraventricular tachycardia: Experience with propafenone. – Angiology, 1989; 40: 563-568.Chimenti M. et al. Tolerance and efficacy of flecainide versus propafenone for the long-term management of paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. – Circulation, 1993; 88: I-446 (abstract).Chimenti M. et al. Tolerance and efficacy of flecainide versus propafenone for the long-term management of paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. – Circulation, 1993; 88: I-446 (abstract).Prichett E.L. et al. Comparison of mortality in patients treated with propafenone to those treated with a variaty of antiarrhythmic drugs for supraventricular arrhythmias. – Am. J.Cardiol., 1993; 72: 108-110.Prichett E.L. et al. Comparison of mortality in patients treated with propafenone to those treated with a variaty of antiarrhythmic drugs for supraventricular arrhythmias. – Am. J.Cardiol., 1993; 72: 108-110.

The authors declare that there are no conflicts of interest present.